About the Author |
|
xix | |
About the Technical Reviewers |
|
xxi | |
Acknowledgments |
|
xxiii | |
Foreword |
|
xxv | |
Introduction |
|
xxvii | |
Part I: Gang of Four Patterns |
|
1 | (408) |
|
Chapter 1 Singleton Pattern |
|
|
3 | (16) |
|
|
3 | (1) |
|
|
3 | (1) |
|
|
3 | (1) |
|
|
4 | (1) |
|
|
4 | (3) |
|
|
4 | (1) |
|
|
5 | (1) |
|
|
5 | (1) |
|
|
6 | (1) |
|
|
7 | (1) |
|
|
7 | (12) |
|
|
11 | (1) |
|
|
12 | (2) |
|
|
14 | (1) |
|
|
15 | (4) |
|
Chapter 2 Prototype Pattern |
|
|
19 | (14) |
|
|
19 | (1) |
|
|
19 | (1) |
|
|
19 | (1) |
|
|
20 | (1) |
|
|
20 | (6) |
|
|
20 | (2) |
|
|
22 | (1) |
|
|
23 | (2) |
|
|
25 | (1) |
|
|
26 | (7) |
|
|
29 | (2) |
|
|
31 | (2) |
|
Chapter 3 Builder Pattern |
|
|
33 | (22) |
|
|
33 | (1) |
|
|
33 | (1) |
|
|
34 | (1) |
|
|
34 | (1) |
|
|
35 | (7) |
|
|
36 | (1) |
|
|
36 | (2) |
|
|
38 | (4) |
|
|
42 | (1) |
|
|
42 | (13) |
|
|
46 | (1) |
|
Modified Package Explorer View |
|
|
46 | (2) |
|
|
48 | (4) |
|
|
52 | (1) |
|
|
53 | (2) |
|
Chapter 4 Factory Method Pattern |
|
|
55 | (12) |
|
|
55 | (1) |
|
|
55 | (1) |
|
|
56 | (1) |
|
|
56 | (1) |
|
|
57 | (6) |
|
|
57 | (1) |
|
|
58 | (1) |
|
|
58 | (3) |
|
|
61 | (1) |
|
|
61 | (2) |
|
|
63 | (1) |
|
|
63 | (1) |
|
|
63 | (4) |
|
Chapter 5 Abstract Factory Pattern |
|
|
67 | (20) |
|
|
67 | (1) |
|
|
67 | (1) |
|
|
68 | (1) |
|
|
68 | (1) |
|
|
68 | (8) |
|
|
70 | (1) |
|
|
71 | (1) |
|
|
72 | (4) |
|
|
76 | (1) |
|
|
76 | (11) |
|
Simple Factory Pattern Code Snippet |
|
|
77 | (1) |
|
Factory Method Pattern Code Snippet |
|
|
78 | (1) |
|
Abstract Factory Pattern Code Snippet |
|
|
78 | (1) |
|
|
79 | (1) |
|
|
80 | (1) |
|
|
80 | (5) |
|
|
85 | (2) |
|
|
87 | (16) |
|
|
87 | (1) |
|
|
87 | (1) |
|
|
87 | (1) |
|
|
88 | (1) |
|
|
88 | (4) |
|
|
88 | (1) |
|
|
89 | (1) |
|
|
90 | (2) |
|
|
92 | (1) |
|
|
92 | (11) |
|
|
93 | (2) |
|
Output Without Lazy Instantiation |
|
|
95 | (1) |
|
|
96 | (1) |
|
Output with Lazy Instantiation |
|
|
96 | (1) |
|
|
96 | (2) |
|
Modified Package Explorer View |
|
|
98 | (1) |
|
|
99 | (2) |
|
|
101 | (2) |
|
Chapter 7 Decorator Pattern |
|
|
103 | (14) |
|
|
103 | (1) |
|
|
103 | (1) |
|
|
103 | (2) |
|
|
105 | (1) |
|
|
106 | (5) |
|
|
106 | (1) |
|
|
107 | (1) |
|
|
107 | (3) |
|
|
110 | (1) |
|
|
111 | (6) |
|
Chapter 8 Adapter Pattern |
|
|
117 | (18) |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
119 | (13) |
|
|
120 | (1) |
|
|
120 | (1) |
|
|
121 | (2) |
|
|
123 | (1) |
|
|
123 | (1) |
|
|
123 | (1) |
|
Key Characteristics of the Modified Implementation |
|
|
124 | (2) |
|
Modified Package Explorer View |
|
|
126 | (1) |
|
|
127 | (3) |
|
|
130 | (1) |
|
|
130 | (2) |
|
|
132 | (3) |
|
|
135 | (12) |
|
|
135 | (1) |
|
|
135 | (1) |
|
|
135 | (1) |
|
|
136 | (1) |
|
|
136 | (8) |
|
|
137 | (1) |
|
|
138 | (1) |
|
|
139 | (4) |
|
|
143 | (1) |
|
|
144 | (3) |
|
Chapter 10 Flyweight Pattern |
|
|
147 | (18) |
|
|
147 | (1) |
|
|
147 | (1) |
|
|
148 | (1) |
|
|
148 | (1) |
|
|
149 | (10) |
|
|
150 | (1) |
|
|
150 | (1) |
|
|
151 | (6) |
|
|
157 | (2) |
|
|
159 | (1) |
|
|
159 | (6) |
|
Chapter 11 Composite Pattern |
|
|
165 | (14) |
|
|
165 | (1) |
|
|
165 | (1) |
|
|
166 | (1) |
|
|
166 | (1) |
|
|
166 | (10) |
|
|
167 | (1) |
|
|
168 | (1) |
|
|
169 | (5) |
|
|
174 | (2) |
|
|
176 | (3) |
|
Chapter 12 Bridge Pattern |
|
|
179 | (14) |
|
|
179 | (1) |
|
|
179 | (1) |
|
|
179 | (1) |
|
|
180 | (1) |
|
|
180 | (10) |
|
|
183 | (1) |
|
|
184 | (1) |
|
|
185 | (1) |
|
|
185 | (4) |
|
|
189 | (1) |
|
|
190 | (3) |
|
Chapter 13 Visitor Pattern |
|
|
193 | (24) |
|
|
193 | (1) |
|
|
193 | (1) |
|
|
194 | (1) |
|
|
194 | (1) |
|
|
194 | (19) |
|
|
195 | (1) |
|
|
196 | (1) |
|
|
196 | (2) |
|
|
198 | (1) |
|
|
198 | (6) |
|
|
204 | (1) |
|
Modified Package Explorer View |
|
|
204 | (2) |
|
|
206 | (6) |
|
|
212 | (1) |
|
|
213 | (4) |
|
Chapter 14 Observer Pattern |
|
|
217 | (16) |
|
|
217 | (1) |
|
|
217 | (3) |
|
|
220 | (1) |
|
|
220 | (1) |
|
|
221 | (6) |
|
|
222 | (1) |
|
|
222 | (2) |
|
|
224 | (3) |
|
|
227 | (1) |
|
|
227 | (1) |
|
|
227 | (6) |
|
Chapter 15 Strategy (Policy) Pattern |
|
|
233 | (18) |
|
|
233 | (1) |
|
|
233 | (1) |
|
|
233 | (1) |
|
|
234 | (1) |
|
|
234 | (6) |
|
|
235 | (1) |
|
|
235 | (2) |
|
|
237 | (3) |
|
|
240 | (1) |
|
|
240 | (11) |
|
Chapter 16 Template Method Pattern |
|
|
251 | (12) |
|
|
251 | (1) |
|
|
251 | (1) |
|
|
251 | (1) |
|
|
252 | (1) |
|
|
252 | (4) |
|
|
252 | (1) |
|
|
253 | (1) |
|
|
254 | (2) |
|
|
256 | (1) |
|
|
256 | (7) |
|
|
257 | (3) |
|
|
260 | (3) |
|
Chapter 17 Command Pattern |
|
|
263 | (22) |
|
|
263 | (1) |
|
|
263 | (1) |
|
|
263 | (1) |
|
|
264 | (1) |
|
|
264 | (6) |
|
|
265 | (1) |
|
|
266 | (1) |
|
|
267 | (3) |
|
|
270 | (1) |
|
|
270 | (15) |
|
|
271 | (1) |
|
Modified Package Explorer View |
|
|
272 | (2) |
|
|
274 | (6) |
|
|
280 | (5) |
|
Chapter 18 lterator Pattern |
|
|
285 | (18) |
|
|
285 | (1) |
|
|
285 | (1) |
|
|
286 | (1) |
|
|
287 | (1) |
|
|
287 | (10) |
|
|
288 | (2) |
|
|
290 | (1) |
|
|
291 | (2) |
|
|
293 | (1) |
|
Key Characteristics of the Second Implementation |
|
|
294 | (1) |
|
|
294 | (2) |
|
|
296 | (1) |
|
|
297 | (6) |
|
|
299 | (3) |
|
|
302 | (1) |
|
Chapter 19 Memento Pattern |
|
|
303 | (26) |
|
|
303 | (1) |
|
|
303 | (1) |
|
|
303 | (1) |
|
|
304 | (1) |
|
|
304 | (6) |
|
|
305 | (1) |
|
|
306 | (1) |
|
|
306 | (3) |
|
|
309 | (1) |
|
|
310 | (19) |
|
|
311 | (1) |
|
|
312 | (1) |
|
|
313 | (8) |
|
Shallow Copy vs. Deep Copy in Java |
|
|
321 | (8) |
|
|
329 | (24) |
|
|
329 | (1) |
|
|
329 | (1) |
|
|
330 | (1) |
|
|
330 | (1) |
|
|
330 | (10) |
|
|
332 | (1) |
|
|
332 | (2) |
|
|
334 | (1) |
|
|
335 | (4) |
|
|
339 | (1) |
|
|
340 | (13) |
|
Modified Package Explorer View |
|
|
343 | (2) |
|
|
345 | (5) |
|
|
350 | (3) |
|
Chapter 21 Mediator Pattern |
|
|
353 | (24) |
|
|
353 | (1) |
|
|
353 | (1) |
|
|
353 | (1) |
|
|
354 | (1) |
|
|
355 | (18) |
|
|
356 | (1) |
|
|
357 | (2) |
|
|
359 | (4) |
|
|
363 | (1) |
|
|
363 | (1) |
|
|
363 | (2) |
|
|
365 | (1) |
|
Modified Package Explorer View |
|
|
366 | (1) |
|
|
367 | (5) |
|
|
372 | (1) |
|
|
373 | (1) |
|
|
373 | (4) |
|
Chapter 22 Chain-of-Responsibility Pattern |
|
|
377 | (12) |
|
|
377 | (1) |
|
|
377 | (1) |
|
|
378 | (1) |
|
|
378 | (1) |
|
|
379 | (7) |
|
|
380 | (1) |
|
|
381 | (1) |
|
|
382 | (3) |
|
|
385 | (1) |
|
|
386 | (3) |
|
Chapter 23 Interpreter Pattern |
|
|
389 | (20) |
|
|
389 | (1) |
|
|
389 | (2) |
|
|
391 | (1) |
|
|
391 | (1) |
|
|
391 | (16) |
|
|
393 | (1) |
|
|
394 | (1) |
|
|
395 | (4) |
|
|
399 | (1) |
|
|
400 | (1) |
|
|
400 | (1) |
|
|
400 | (1) |
|
Modified Package Explorer View |
|
|
400 | (1) |
|
|
401 | (5) |
|
|
406 | (1) |
|
|
406 | (1) |
|
|
407 | (2) |
Part II: Additional Design Patterns |
|
409 | (50) |
|
Chapter 24 Simple Factory Pattern |
|
|
411 | (10) |
|
|
411 | (1) |
|
|
411 | (1) |
|
|
411 | (1) |
|
|
412 | (1) |
|
|
413 | (6) |
|
|
413 | (1) |
|
|
414 | (1) |
|
|
415 | (2) |
|
|
417 | (2) |
|
|
419 | (2) |
|
Chapter 25 Null Object Pattern |
|
|
421 | (16) |
|
|
421 | (5) |
|
|
422 | (2) |
|
|
424 | (1) |
|
Analysis with an Unwanted Input |
|
|
424 | (1) |
|
|
425 | (1) |
|
|
425 | (1) |
|
|
425 | (1) |
|
|
426 | (1) |
|
|
426 | (1) |
|
|
426 | (7) |
|
|
427 | (1) |
|
|
428 | (1) |
|
|
429 | (3) |
|
|
432 | (1) |
|
|
433 | (1) |
|
|
433 | (4) |
|
|
437 | (22) |
|
|
437 | (3) |
|
|
438 | (1) |
|
|
439 | (1) |
|
|
439 | (1) |
|
|
440 | (1) |
|
|
440 | (1) |
|
|
441 | (1) |
|
|
442 | (11) |
|
|
442 | (2) |
|
|
444 | (1) |
|
|
444 | (8) |
|
|
452 | (1) |
|
|
453 | (8) |
|
|
455 | (4) |
Part III: Final Discussions on Design Patterns |
|
459 | (22) |
|
Chapter 27 Criticisms of Design Patterns |
|
|
461 | (6) |
|
|
463 | (4) |
|
Chapter 28 AntiPatterns: Avoid the Common Mistakes |
|
|
467 | (8) |
|
|
467 | (1) |
|
Brief History of Antipatterns |
|
|
468 | (1) |
|
|
469 | (2) |
|
|
471 | (1) |
|
|
471 | (4) |
|
|
475 | (6) |
Appendix A: A Brief Overview of GoF Design Patterns |
|
481 | (8) |
|
|
482 | (1) |
|
|
483 | (1) |
|
|
483 | (1) |
|
|
484 | (2) |
|
|
486 | (3) |
Appendix B: Winning Notes and the Road Ahead |
|
489 | (2) |
Appendix C: Bibliography |
|
491 | (2) |
Index |
|
493 | |
9780444641793 |
|
Contributors |
|
xiii | |
Preface |
|
xvii | |
1 Metabolic Screening of Wine (Grapevine) Resveratrol |
|
1 | (30) |
|
|
|
|
|
|
1 | (1) |
|
Resveratrol Concentration in Grapes and Wine |
|
|
2 | (4) |
|
Bioavailability and Pharmacokinetics |
|
|
6 | (2) |
|
|
8 | (1) |
|
Antimicrobial Activity of Wine |
|
|
9 | (1) |
|
Metabolic Engineering of Resveratrol in Plants and Microorganisms |
|
|
9 | (1) |
|
|
10 | (13) |
|
|
17 | (2) |
|
|
19 | (4) |
|
|
23 | (2) |
|
|
25 | (1) |
|
|
25 | (1) |
|
|
26 | (5) |
2 Sweet Cherry Phenolic Compounds: Identification, Characterization, and Health Benefits |
|
31 | (48) |
|
|
|
|
|
|
|
32 | (1) |
|
Phenolic Composition of Sweet Cherries |
|
|
33 | (10) |
|
|
37 | (2) |
|
|
39 | (4) |
|
Determination of Phenolics in Sweet Cherries |
|
|
43 | (13) |
|
|
43 | (1) |
|
|
44 | (1) |
|
Phenolic Extraction Procedures |
|
|
44 | (2) |
|
Purification and Fractionation |
|
|
46 | (1) |
|
Methods to Determine Phenolic Compounds |
|
|
46 | (1) |
|
Spectrophotometric Methods |
|
|
47 | (1) |
|
Liquid Chromatographic Methods |
|
|
47 | (1) |
|
|
48 | (1) |
|
|
48 | (1) |
|
Characterization of Phenolic Compounds by HPLC Methods |
|
|
48 | (8) |
|
Health Benefits of Sweet Cherries |
|
|
56 | (14) |
|
Antimicrobial and Antifungal Activities |
|
|
57 | (2) |
|
|
59 | (2) |
|
|
61 | (1) |
|
Radical Scavenging Capacity |
|
|
61 | (1) |
|
|
62 | (1) |
|
|
63 | (1) |
|
|
63 | (1) |
|
Antiinflammatory Protection |
|
|
64 | (1) |
|
|
65 | (1) |
|
|
66 | (2) |
|
|
68 | (1) |
|
Cardiovascular Protection |
|
|
69 | (1) |
|
|
70 | (1) |
|
|
70 | (1) |
|
|
70 | (2) |
|
|
72 | (6) |
|
|
78 | (1) |
3 Phenolic Compounds: A Good Choice Against Chronic Degenerative Diseases |
|
79 | (30) |
|
|
|
|
|
Carlos Enrique Ochoa-Velasco |
|
|
|
79 | (1) |
|
|
80 | (1) |
|
|
81 | (1) |
|
|
82 | (2) |
|
|
83 | (1) |
|
|
84 | (7) |
|
|
87 | (4) |
|
|
91 | (2) |
|
|
93 | (1) |
|
|
93 | (4) |
|
|
96 | (1) |
|
|
97 | (2) |
|
|
98 | (1) |
|
|
99 | (1) |
|
|
100 | (1) |
|
|
101 | (1) |
|
|
102 | (7) |
4 Recent Developments in the Quest for Novel Microbial Natural Products |
|
109 | (44) |
|
|
|
|
109 | (1) |
|
Classical Approach of Microbial NP Discovery |
|
|
110 | (1) |
|
Exploring Microbes From Unique Ecological Habitats |
|
|
111 | (1) |
|
|
112 | (1) |
|
|
113 | (5) |
|
NPs From Symbiotic Microorganisms |
|
|
118 | (5) |
|
NPs From Endophytic Fungi |
|
|
123 | (2) |
|
Single-Cell Genomics in Microbial NPs Discovery |
|
|
125 | (1) |
|
Use of Diverse Culture Conditions |
|
|
125 | (3) |
|
NPs From Environmental DNA (e-DNA) |
|
|
128 | (4) |
|
Activation of Cryptic Pathways |
|
|
132 | (7) |
|
|
133 | (2) |
|
Use of Environmental Cues |
|
|
135 | (1) |
|
|
136 | (1) |
|
Awakening of Biosynthetic Pathway Activators, Silencing of Repressors, and Use of Strong Promoters |
|
|
137 | (1) |
|
RNA Polymerase Transcriptional and Ribosome Translational Engineering |
|
|
138 | (1) |
|
|
139 | (1) |
|
Emerging Dereplication Approaches |
|
|
139 | (5) |
|
|
144 | (1) |
|
|
144 | (1) |
|
|
145 | (8) |
5 Mycosporine-Like Amino Acids as Multifunctional Secondary Metabolites in Cyanobacteria: From Biochemical to Application Aspects |
|
153 | (42) |
|
|
Rungaroon Waditee-Sirisattha |
|
|
|
154 | (1) |
|
Basic Description of MAAs |
|
|
155 | (3) |
|
|
155 | (1) |
|
Basic Characteristics of MAAs |
|
|
155 | (2) |
|
|
157 | (1) |
|
Molecular Structure of MAAs |
|
|
158 | (4) |
|
General Structure of MAAs |
|
|
158 | (1) |
|
Resonance Delocalization in the Molecular Structure of MAAs |
|
|
159 | (1) |
|
The Effects of Environmental Factors on the Molecular Structure of MAAs |
|
|
160 | (1) |
|
Determination of the Molecular Structure of MAAs |
|
|
160 | (2) |
|
Biosynthetic Pathway of MAAs |
|
|
162 | (4) |
|
Biosynthetic Pathway of 4-Deoxygadusol, the Common Precursor Compound of MAAs |
|
|
162 | (1) |
|
Gene Clusters for Biosynthesis of MAAs |
|
|
163 | (3) |
|
|
166 | (2) |
|
|
166 | (1) |
|
Effects of Salt and Thermal Stresses |
|
|
167 | (1) |
|
Effects of Nutrient Availability |
|
|
167 | (1) |
|
Biological Activities and Functions |
|
|
168 | (2) |
|
Photoprotectant and Sunscreen Functions |
|
|
168 | (1) |
|
Antioxidant and Antiinflammation |
|
|
168 | (1) |
|
|
169 | (1) |
|
|
170 | (1) |
|
Recent Patents Related to MAAs |
|
|
171 | (17) |
|
|
188 | (1) |
|
|
188 | (1) |
|
|
189 | (1) |
|
|
189 | (6) |
6 Basic and Clinical Studies With Marine LipoFishins and Vegetal Favalins in Neurodegeneration and Age-Related Disorders |
|
195 | (32) |
|
|
|
|
|
|
|
|
|
|
195 | (3) |
|
|
198 | (8) |
|
|
206 | (1) |
|
|
206 | (1) |
|
|
206 | (2) |
|
AntiGan (E-Congerine-10423) |
|
|
208 | (2) |
|
|
210 | (1) |
|
Atremorine (E-PodoFavalin-15999) |
|
|
211 | (8) |
|
|
219 | (1) |
|
|
220 | (1) |
|
|
221 | (6) |
7 Terpenoids as Emerging Therapeutic Agents: Cellular Targets and Mechanisms of Action against Protozoan Parasites |
|
227 | (24) |
|
|
|
|
|
|
|
|
228 | (1) |
|
|
229 | (1) |
|
Mechanisms of Action Involving Interaction With Specific Parasite Enzymes and Other Macromolecules |
|
|
230 | (5) |
|
Terpenoids Interfere With DNA Metabolism |
|
|
231 | (1) |
|
Terpenoids Interact With Calcium Transporters |
|
|
232 | (1) |
|
Terpenoids Inhibit Fatty Acid Metabolism |
|
|
233 | (1) |
|
Terpenoids Inhibit Parasite Proteases |
|
|
233 | (1) |
|
Terpenoids Interact With Glyceraldehyde-3-Phosphate Dehydrogenase |
|
|
233 | (2) |
|
Terpenoids Inhibit Biosynthesis of Other Structurally Similar Compounds in Parasites |
|
|
235 | (1) |
|
Terpenoids Induce Oxidative Stress in Parasites |
|
|
236 | (2) |
|
Terpenoids Induce Morphological and Ultrastructural Changes in Parasites |
|
|
238 | (4) |
|
|
238 | (2) |
|
|
240 | (2) |
|
Terpenoids Arrest Parasites' Cell Cycle |
|
|
242 | (1) |
|
Terpenoids Interactions With Parasites Proteins as Predicted In Silico |
|
|
243 | (1) |
|
Terpenoids Mediate Parasite Killing by the Host |
|
|
244 | (1) |
|
|
245 | (1) |
|
|
246 | (1) |
|
|
246 | (1) |
|
|
246 | (5) |
8 Bioactive Sesquiterpene Coumarins From Plants |
|
251 | (32) |
|
|
|
|
|
251 | (2) |
|
Structure Type and Important Representatives |
|
|
253 | (16) |
|
Subtype A: Umbelliferone-Derived SCs |
|
|
253 | (9) |
|
Subtype B: Scopoletin-Derived SCs |
|
|
262 | (1) |
|
Subtype C: Isofraxidin-Derived SCs |
|
|
262 | (2) |
|
Subtype D: Other Type SCs |
|
|
264 | (5) |
|
Physical and Chemical Properties and Spectral Characteristics for Identification |
|
|
269 | (1) |
|
Physical and Chemical Properties |
|
|
269 | (1) |
|
Spectral Characteristics of SCs |
|
|
270 | (1) |
|
|
270 | (7) |
|
|
270 | (5) |
|
Anti inflammatory Activity |
|
|
275 | (1) |
|
Antibacterial and Antivirus Activities |
|
|
276 | (1) |
|
|
276 | (1) |
|
Biosynthetic Pathway and Biotransformation |
|
|
277 | (2) |
|
|
277 | (1) |
|
|
278 | (1) |
|
|
279 | (1) |
|
|
280 | (3) |
9 Assessing Herb-Drug Interactions of Herbal Products With Therapeutic Agents for Metabolic Diseases: Analytical and Regulatory Perspectives |
|
283 | (40) |
|
|
|
|
Introduction: Herb-Drug Interactions (HDIs) |
|
|
284 | (1) |
|
|
285 | (6) |
|
Pharmacokinetic Interactions |
|
|
285 | (6) |
|
Pharmacodynamic Interactions |
|
|
291 | (1) |
|
Chemical Complexity in NPs |
|
|
291 | (1) |
|
Novel In Silico, In Vitro, and In Vivo Approaches in HDI Screening |
|
|
291 | (12) |
|
In Silico Prediction of HDIs |
|
|
292 | (2) |
|
In Vitro Screening of HDIs |
|
|
294 | (9) |
|
Analytical Tools in HDI Screening |
|
|
303 | (3) |
|
Fluorometric High-Throughput Screening (HTS) Assays |
|
|
303 | (1) |
|
Liquid Chromatography-Mass Spectrometry in HDIs Screening |
|
|
303 | (3) |
|
|
306 | (1) |
|
A Study on HDIs of Diabetes |
|
|
306 | (2) |
|
|
308 | (3) |
|
Current Regulatory Scenario in DI Reporting of HPs |
|
|
311 | (1) |
|
Conclusion and Future Perspective |
|
|
312 | (1) |
|
|
313 | (1) |
|
|
313 | (1) |
|
|
313 | (2) |
|
|
315 | (8) |
10 Natural Products for the Management of Diabetes |
|
323 | (52) |
|
|
|
|
324 | (1) |
|
Natural Products Which Control Glucose Absorption |
|
|
325 | (2) |
|
Natural Products Which Control GLP-1 Homeostasis |
|
|
327 | (1) |
|
Natural Products Which Improve II-Cell Function |
|
|
328 | (2) |
|
Natural Products Which Improve Insulin Sensitivity |
|
|
330 | (2) |
|
Antidiabetic Natural Products With Multiple Mechanisms |
|
|
332 | (6) |
|
Examples of Clinical Trials on Antidiabetic Plants and Natural Products |
|
|
338 | (29) |
|
|
367 | (1) |
|
|
367 | (1) |
|
|
367 | (1) |
|
|
368 | (7) |
11 Limonoids: Structure-Activity Relationship Studies and Anticancer Properties |
|
375 | (26) |
|
Kalyan C. Nagulapalli Venkata |
|
|
|
|
|
375 | (1) |
|
SAR and Anticancer Activity |
|
|
376 | (18) |
|
|
394 | (3) |
|
|
397 | (1) |
|
|
398 | (3) |
12 Anticancer Potential of Flavonoids: Chemistry, Biological Activities, and Future Perspectives |
|
401 | (30) |
|
|
|
|
401 | (2) |
|
Chemistry and Spectral Properties |
|
|
403 | (2) |
|
Molecular Mechanism of Action |
|
|
405 | (4) |
|
Anticancer Evaluation of Flavonoids (In Vivo and In Vitro Studies) |
|
|
409 | (2) |
|
Anticancer Flavonoids in Clinical Trials |
|
|
411 | (1) |
|
|
412 | (1) |
|
Multidrug Resistance Properties |
|
|
412 | (8) |
|
|
420 | (1) |
|
|
421 | (1) |
|
|
421 | (1) |
|
|
422 | (9) |
13 Chemistry and Biology of Salicyl-Capped Siderophores |
|
431 | (60) |
|
|
|
|
|
|
|
431 | (1) |
|
Structures and Origins of Salicyl-Capped Siderophores |
|
|
432 | (20) |
|
Biosynthesis and Transport Pathways of Salicyl-Capped Siderophores |
|
|
452 | (12) |
|
Pyochelin/Enantio-Pyochelin Biosynthesis |
|
|
452 | (3) |
|
Watasemycirahiazostatin/lsopyochelin Biosynthesis |
|
|
455 | (1) |
|
Yersiniabactin Biosynthesis |
|
|
456 | (2) |
|
|
458 | (1) |
|
Transport Pathways of Bacteria |
|
|
458 | (6) |
|
Biological Functions of Salicyl-Capped Siderophores |
|
|
464 | (5) |
|
Biological Functions of Pyochelin Derivatives |
|
|
464 | (1) |
|
Biological Functions of MBT Derivatives and Related Natural Products |
|
|
465 | (4) |
|
Total Synthesis and Derivatives of Salicyl-Capped Siderophores |
|
|
469 | (3) |
|
Salicyl-Thiazoline Siderophores |
|
|
469 | (2) |
|
Salicyl-Oxazoline Siderophores |
|
|
471 | (1) |
|
Application of Salicyl-Capped Siderophores |
|
|
472 | (10) |
|
|
473 | (1) |
|
|
473 | (2) |
|
|
475 | (7) |
|
|
482 | (1) |
|
|
483 | (1) |
|
|
484 | (7) |
14 Southern Brazilian Hypericum Species, Promising Sources of Bioactive Metabolites |
|
491 | (18) |
|
Gabriela de Carvalho Meirelles |
|
|
|
|
|
|
491 | (1) |
|
|
492 | (2) |
|
|
494 | (6) |
|
|
494 | (2) |
|
Phloroglucinol Derivatives |
|
|
496 | (2) |
|
|
498 | (1) |
|
|
498 | (1) |
|
Flavonoids and Chlorogenic Acid |
|
|
499 | (1) |
|
|
500 | (1) |
|
|
501 | (2) |
|
Antinociceptive and Antidepressant Activities |
|
|
501 | (2) |
|
|
503 | (1) |
|
|
503 | (1) |
|
|
503 | (4) |
|
|
507 | (2) |
15 Citrus Polymethoxyflavones: Biofunctional Molecules of Therapeutic Interest |
|
509 | (22) |
|
|
|
509 | (1) |
|
|
510 | (3) |
|
Isolation, Characterization, and Analysis of PMFs |
|
|
513 | (2) |
|
|
515 | (1) |
|
|
516 | (2) |
|
Biological Activity of PMFs and Their Chemical Structures |
|
|
518 | (8) |
|
|
518 | (1) |
|
Antiinflammatory Activity |
|
|
519 | (2) |
|
|
521 | (2) |
|
Antiangiogenesis Activity |
|
|
523 | (1) |
|
Antimicrobial and Antiviral Activity |
|
|
523 | (2) |
|
Antiadipogenesis Activity |
|
|
525 | (1) |
|
|
526 | (1) |
|
|
527 | (1) |
|
|
527 | (3) |
|
|
530 | (1) |
Index |
|
531 | |